English
|
正體中文
|
简体中文
|
全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 848541 線上人數 : 1131
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
搜尋範圍
全部NHRI
免疫醫學研究中心
林文傑
--會議論文/會議摘要
--期刊論文
查詢小技巧:
您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
進階搜尋
主頁
‧
登入
‧
上傳
‧
說明
‧
關於NHRI
‧
管理
國家衛生研究院 NHRI
>
免疫醫學研究中心
>
林文傑
>
依題名瀏覽
依作者瀏覽
依日期瀏覽
依資料類型瀏覽
社群詳細資訊
簡介:
林文傑(Wen-Jye Lin)
ORCID:0000-0001-8821-9813
資料載入中.....
子類別
會議論文/會議摘要
[
1
/2]
期刊論文
[
18
/18]
鄰近社群
朱清良(2005-2010)
[
13
/14]
林素珍(2008-2009)
[
2
/2]
莊宗顯
[
85
/87]
莊懷佳
[
50
/54]
蘇郁文
[
23
/23]
謝世良
[
6
/6]
譚澤華
[
70
/76]
高承源
[
25
/27]
黃慶裕
[
10
/11]
其他
[
7
/8]
社群統計
近3年內發表的文件:4(20.00%)
含全文筆數:19(95.00%)
文件下載次數統計
下載大於0次:19(100.00%)
下載大於100次:17(89.47%)
檔案下載總次數:7471(0.14%)
最後更新時間: 2024-11-28 13:45
上傳排行
資料載入中.....
下載排行
資料載入中.....
最近上傳
PTEN acts as a crucial inflammatory...
DUSP22 inhibits lung tumorigenesis ...
Suppression of androgen receptor si...
Single-cell RNA sequencing uncovers...
Ultra-small platinum nanoparticle-e...
Prognostic significance of o-glcnac...
Molecular mechanisms of dual-specif...
DUSP22 suppresses prostate cancer p...
PP4 deficiency leads to DNA replica...
Subnanometer gold clusters adhere t...
跳至:
(選擇年份)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(選擇月份)
January
February
March
April
May
June
July
August
September
October
November
December
或輸入年份:
由新到舊排序
由最舊的開始
顯示項目1-20 / 20. (共1頁)
1
每頁顯示[
10
|
25
|
50
]項目
日期
題名
關聯
2024-07-19
PTEN acts as a crucial inflammatory checkpoint controlling TLR9/IL-6 axis in B cells
iScience. 2024 Jul 19;27(7):Article number 110388.
2024-06-14
DUSP22 inhibits lung tumorigenesis by suppression of EGFR/c-Met signaling
Cell Death Discovery. 2024 Jun 14;10:Article number 285.
2023-04
Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis
Cancer Science. 2023 Apr;114(4):1479-1490.
2022-02-18
Single-cell RNA sequencing uncovers the individual alteration of intestinal mucosal immunocytes in Dusp6 knockout mice
iScience. 2022 Feb 18;25(2):Article number 103738.
2021-08-16
Ultra-small platinum nanoparticle-enabled catalysis and corrosion susceptibility reverse tumor hypoxia for cancer chemoimmunotherapy
ACS Applied Bio Materials. 2021 Aug 16;4(8):6527-6538.
2021-08-12
Prognostic significance of o-glcnac and PKM2 in hormone receptor-positive and HER2-nonenriched breast cancer
Diagnostics. 2021 Aug 12;11(8):Article number 1460.
2019-12
DUSP22 suppresses prostate cancer proliferation by targeting the EGFR-AR axis
FASEB Journal. 2019 Dec 5;33(12):14653-14667.
2019-07
PP4 deficiency leads to DNA replication stress that impairs immunoglobulin class switch efficiency
Cell Death and Differentiation. 2019 Jul;26 (7):1221-1234.
2019-02
Molecular mechanisms of dual-specificity phosphatase 22 (DUSP22) in suppression of tumorigenesis: The potential involvement of the EGFR/PD-L1 axis
Cancer Immunology Research. 2019 Feb;7(2):B172.
2019-01
CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer clls
Cancer Science. 2019 Jan;110(1):279-288.
2018-05
Subnanometer gold clusters adhere to lipid a for protection against endotoxin-induced sepsis
Nano Letters. 2018 May;18(5):2864-2869.
2018-03
C‐C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment
Cancer Science. 2018 Mar;109(3):724-731.
2017-02
Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22-CCR4 axis
Oncotarget. 2017 Feb;8(6):9739-9751.
2016-08
Molecular mechanisms of DUSP22 ablation in enhancing EGFR-mediated lung tumor development: Potential involvement of immunosuppression
European Journal of Immunology. 2016 Aug;46(Suppl. 1):240.
2016-02
Serum chemokine (CC motif) ligand 2 level as a diagnostic, predictive, and prognostic biomarker for prostate cancer
Oncotarget. 2016 Feb;7(7):8389-8398.
2014-09-12
PP4 is essential for germinal center formation and class switch recombination in mice
PLoS ONE. 2014 Sep 12;9(9):Article number e107505.
2014-08
Outcomes and predictive factors of prostate cancer patients with extremely high prostate-specific antigen level
Journal of Cancer Research and Clinical Oncology. 2014 Aug;140(8):1413-1419.
2014-01
Androgen receptor, ccl2, and epithelial-mesenchymal transition: A dangerous affair in the tumor microenvironment
OncoImmunology. 2014 Jan;3(2):Article number e27871.
2013-09-15
Infiltrating macrophages promote prostate tumorigenesis via modulating Androgen Receptor-Mediated CCL4-STAT3 signaling
Cancer Research. 2013 Sep 15;73(18):5633-5646.
2013-09
Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation
EMBO Molecular Medicine. 2013 Sep;5(9):1383-1401.
顯示項目1-20 / 20. (共1頁)
1
每頁顯示[
10
|
25
|
50
]項目
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
回饋